New radiation treatment for chest and upper abdomen tumors
Part of Cancer, Digestive system, Hormones & metabolism, Lungs & breathing clinical trials.
This trial tests a new radiation treatment workflow that guides the radiation beam more precisely when you hold your breath. It may help target tumors in the chest or upper belly while sparing healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your tumor must be in the chest or upper belly area.
- You must be scheduled to receive a type of radiation treatment called SBRT (stereotactic body radiation therapy).
- You must be able to hold your breath during the radiation treatment.
- You should be in good overall health, able to do light work or be fully active.
- You must be at least 21 years old and able to give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer, more precise way of giving radiation for lung cancer tumors that are near the center of the chest. The goal is to see if using a smaller treatment area can reduce side effects while still killing the cancer.
This trial compares a newer, more targeted type of radiation (hotspot SABR) with the standard SABR approach for people with early-stage non-small cell lung cancer. The goal is to see if the newer method works just as well or better while possibly reducing side effects.
This trial tests a personalized radiation treatment called SBRT for early-stage non-small cell lung cancer that is located in the outer part of the lung and cannot be removed with surgery. The goal is to see if this approach works well for people who cannot have surgery or choose not to.
This study tests a precise type of radiation called SBRT for small lung cancers located near the center of the chest, close to important structures like the windpipe or heart. The goal is to see if this treatment can safely target the tumor while sparing healthy tissue.
This trial tests whether giving high-precision radiation to a few spots that are growing during immunotherapy (with or without chemotherapy) can help people with advanced lung cancer. It aims to see if treating these limited areas of resistance can extend the time the cancer stays under control.
This trial tests a new way to plan radiation therapy for lung cancer by using a special imaging technique (functional lung imaging) to see which parts of your lungs work best. The goal is to reduce damage to healthy lung tissue while still targeting the cancer.
Hear when a new Lung Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.